Plant Derived Antiviral Products for Potential Treatment of COVID-19: A Review |
| |
Authors: | Rashid Iqbal Khan Mazhar Abbas Khurram Goraya Muhammad Zafar-ul-Hye Subhan Danish |
| |
Institution: | 1 Institute of Hoticultural Sciences, University of Agriculture Faisalabad, Faisalabad, 38000, Pakistan2 Office for Conservation of the Environment, Diwan of Royal Court of Oman, Muscat, 113, Oman3 Department of Soil Science, Faculty of Agricultural Sciences and Technology, Bahauddin Zakariya University, Multan, 60800, Pakistan |
| |
Abstract: | COVID-19 caused by SARS-CoV-2 is declared global pandemic. The
virus owing high resemblance with SARS-CoV and MERS-CoV has been placed
in family of beta-coronavirus. However, transmission and infectivity rate of
COVID-19 is quite higher as compared to other members of family. Effective
management strategy with potential drug availability will break the virus transmission chain subsequently reduce the pressure on the healthcare system. Extensive research trials are underway to develop novel efficient therapeutics against
SARS-CoV-2. In this review, we have discussed the origin and family of coronavirus, structure, genome and pathogenesis of virus SARS-CoV-2 inside human
host cell; comparison among SARS, MERS, SARS-CoV-2 and common flu;
effective management practices; treatment with immunity boosters; available
medication with ongoing clinical trials. We suggest medicinal plants could serve
as potential candidates for drug development against COVID-19 infection. |
| |
Keywords: | Virus human health bat SARS-CoV-2 fever Wuhan |
|
| 点击此处可从《Phyton》浏览原始摘要信息 |
| 点击此处可从《Phyton》下载免费的PDF全文 |
|